Our previous work showed that Gal-9 is associated with a poor prognosis in patients with NPC and induces tumor immune tolerance by mediating the expansion of myeloid-derived suppressor cells in a manner dependent on stimulator of interferon gene (STING) signaling (11). The gene discussed is LGALS9; the disease is nasopharyngeal carcinoma.